SLC37A4
Glucose-6-phosphate exchanger SLC37A4
Also known as: G6PT1_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- O43826
- Gene
- SLC37A4
- Canonical length
- 429 aa
- Protein class
- Human disease related genes, Metabolic proteins, Predicted membrane proteins
OverviewNCBI Gene
No narrative summary is available for SLC37A4 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
429 residues, UniProt reviewed canonical sequence.
>O43826|SLC37A4
1 MAAQGYGYYR TVIFSAMFGG YSLYYFNRKT FSFVMPSLVE EIPLDKDDLG FITSSQSAAY
61 AISKFVSGVL SDQMSARWLF SSGLLLVGLV NIFFAWSSTV PVFAALWFLN GLAQGLGWPP
121 CGKVLRKWFE PSQFGTWWAI LSTSMNLAGG LGPILATILA QSYSWRSTLA LSGALCVVVS
181 FLCLLLIHNE PADVGLRNLD PMPSEGKKGS LKEESTLQEL LLSPYLWVLS TGYLVVFGVK
241 TCCTDWGQFF LIQEKGQSAL VGSSYMSALE VGGLVGSIAA GYLSDRAMAK AGLSNYGNPR
301 HGLLLFMMAG MTVSMYLFRV TVTSDSPKLW ILVLGAVFGF SSYGPIALFG VIANESAPPN
361 LCGTSHAIVG LMANVGGFLA GLPFSTIAKH YSWSTAFWVA EVICAASTAA FFLLRNIRTK
421 MGRVSKKAELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC37A4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 134 nTPM
Expression across tissuesHPA
Tissue
- liver: 134 nTPM
- kidney: 48 nTPM
- pancreas: 38 nTPM
- duodenum: 34 nTPM
- small intestine: 26 nTPM
- epididymis: 19 nTPM
Single-cell type
- proximal tubule cells: 30 nCPM
- podocytes: 15 nCPM
- microglia: 13 nCPM
- loop of henle epithelial cells: 7.5 nCPM
- astrocytes: 7.1 nCPM
- renal collecting duct intercalated cells: 6.6 nCPM
Immune cell
- memory CD8 T-cell: 1.7 nTPM
- intermediate monocyte: 1.6 nTPM
- gdT-cell: 1.4 nTPM
- eosinophil: 1.3 nTPM
- MAIT T-cell: 1.3 nTPM
- naive CD8 T-cell: 1.1 nTPM
Brain region
- medulla oblongata: 1.1 nTPM
- hypothalamus: 0.8 nTPM
- spinal cord: 0.8 nTPM
- choroid plexus: 0.7 nTPM
- white matter: 0.7 nTPM
- cerebral cortex: 0.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC37A4.
Disease | AllUniProt
Conditions SLC37A4 is implicated in, by any mechanism.
- Glycogen storage disease 1B (GSD1B) MIM:232220
- Glycogen storage disease 1C (GSD1C) MIM:232240
- Glycogen storage disease 1D (GSD1D) MIM:232240
- Congenital disorder of glycosylation 2W (CDG2W) MIM:619525
Disease | GeneticClinVar
182 pathogenic / likely-pathogenic of 1,140 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Glucose-6-phosphate transport defect
- Phosphate transport defect
- Congenital disorder of glycosylation, type IIw
- Glycogen storage disease
- Glycogen storage disease, type I
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- gluconeogenesis
- glucose homeostasis
- glucose metabolic process
- glucose-6-phosphate transport
- phosphate ion transmembrane transport
Molecular functions
- glucose 6-phosphate:phosphate antiporter activity
- glucose-6-phosphate transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sugar phosphate transporter
- Major facilitator superfamily
- Major facilitator superfamily domain
- MFS transporter superfamily
- Major Facilitator Superfamily
- Glycerate/sugar phosphate transporter, conserved site
- Organophosphate:Pi Antiporter
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC37A4 as an antibody target. Whether an autoantibody or antibody against SLC37A4 could matter depends on whether native SLC37A4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC37A4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC37A4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...